Bone Health in Pediatric Patients with Neurological Disorders

Overview

Journal Ann Pediatr Endocrinol Metab

Specialty Pediatrics

Date 2020 Apr 8

PMID 32252212

Citations 10

Authors

Ara Ko

Juhyun Kong

Furkat Samadov

Akmal Mukhamedov

Young Mi Kim

Yun-Jin Lee

Sang Ook Nam

Affiliations

Soon will be listed here.

Abstract

Patients with neurological disorders are at high risk of developing osteoporosis, as they possess multiple risk factors leading to low bone mineral density. Such factors include inactivity, decreased exposure to sunlight, poor nutrition, and the use of medication or treatment that can cause lower bone mineral density such as antiepileptic drugs, ketogenic diet, and glucocorticoids. In this article, mechanisms involved in altered bone health in children with neurological disorders and management for patients with epilepsy, cerebral palsy, and Duchenne muscular dystrophy regarding bone health are reviewed.

Citing Articles

The evolution of nutrition management in children with severe neurological impairment with a focus on cerebral palsy.

Oftedal S, McCormack S, Stevenson R, Benfer K, Boyd R, Bell K J Hum Nutr Diet. 2024; 38(1):e13277.

PMID: 38196166 PMC: 11589402. DOI: 10.1111/jhn.13277.

Bone health in children with Angelman syndrome at the ENCORE Expertise Center.

Bindels-de Heus K, Hagenaar D, Mous S, Dekker I, van der Kaay D, Kerkhof G Eur J Pediatr. 2023; 183(1):103-111.

PMID: 37831301 PMC: 10857954. DOI: 10.1007/s00431-023-05231-6.

A Causality between Thyroid Function and Bone Mineral Density in Childhood: Abnormal Thyrotropin May Be Another Pediatric Predictor of Bone Fragility.

Lee D, Ahn M Metabolites. 2023; 13(3).

PMID: 36984812 PMC: 10058985. DOI: 10.3390/metabo13030372.

Incidence of fractures in people with intellectual disabilities over the life course: a retrospective matched cohort study.

Frighi V, Smith M, Andrews T, Clifton L, Collins G, Fuller A EClinicalMedicine. 2022; 52:101656.

PMID: 36313144 PMC: 9596306. DOI: 10.1016/j.eclinm.2022.101656.

Osteogenic Effect of Pregabalin in Human Primary Mesenchymal Stem Cells, Osteoblasts, and Osteosarcoma Cells.

Wagener N, Di Fazio P, Boker K, Matziolis G Life (Basel). 2022; 12(4).

PMID: 35454987 PMC: 9032037. DOI: 10.3390/life12040496.

References

Yasar E, Adiguzel E, Arslan M, Matthews D . Basics of bone metabolism and osteoporosis in common pediatric neuromuscular disabilities. Eur J Paediatr Neurol. 2017; 22(1):17-26. DOI: 10.1016/j.ejpn.2017.08.001. View

Hosseinpour F, Ellfolk M, Norlin M, Wikvall K . Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia. Biochem Biophys Res Commun. 2007; 357(3):603-7. DOI: 10.1016/j.bbrc.2007.03.177. View

Bonjour J, Theintz G, Buchs B, Slosman D, Rizzoli R . Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab. 1991; 73(3):555-63. DOI: 10.1210/jcem-73-3-555. View

Simm P, Bicknell-Royle J, Lawrie J, Nation J, Draffin K, Stewart K . The effect of the ketogenic diet on the developing skeleton. Epilepsy Res. 2017; 136:62-66. DOI: 10.1016/j.eplepsyres.2017.07.014. View

Frost H . Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol. 2003; 275(2):1081-101. DOI: 10.1002/ar.a.10119. View

McDonald D, Kinali M, Gallagher A, Mercuri E, Muntoni F, Roper H . Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol. 2002; 44(10):695-8. DOI: 10.1017/s0012162201002778. View

Soderpalm A, Magnusson P, Ahlander A, Karlsson J, Kroksmark A, Tulinius M . Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul Disord. 2007; 17(11-12):919-28. DOI: 10.1016/j.nmd.2007.05.008. View

Kafali G, Erselcan T, Tanzer F . Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr (Phila). 1999; 38(2):93-8. DOI: 10.1177/000992289903800205. View

Fehlings D, Switzer L, Agarwal P, Wong C, Sochett E, Stevenson R . Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: a systematic review. Dev Med Child Neurol. 2011; 54(2):106-16. DOI: 10.1111/j.1469-8749.2011.04091.x. View

10.

Ali I, Schuh L, Barkley G, Gates J . Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav. 2004; 5(3):296-300. DOI: 10.1016/j.yebeh.2004.02.005. View

11.

Gordon C, Leonard M, Zemel B . 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom. 2014; 17(2):219-24. DOI: 10.1016/j.jocd.2014.01.007. View

12.

von Borstel Smith M, Crofoot K, Rodriguez-Proteau R, Filtz T . Effects of phenytoin and carbamazepine on calcium transport in Caco-2 cells. Toxicol In Vitro. 2007; 21(5):855-62. DOI: 10.1016/j.tiv.2007.02.008. View

13.

Kulak C, Borba V, Bilezikian J, Silvado C, de Paola L, Boguszewski C . Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr. 2004; 62(4):940-8. DOI: 10.1590/s0004-282x2004000600003. View

14.

Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y . Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 2001; 57(3):445-9. DOI: 10.1212/wnl.57.3.445. View

15.

Bushby K, Finkel R, Birnkrant D, Case L, Clemens P, Cripe L . Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2009; 9(1):77-93. DOI: 10.1016/S1474-4422(09)70271-6. View

16.

Ross A, Manson J, Abrams S, Aloia J, Brannon P, Clinton S . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2010; 96(1):53-8. PMC: 3046611. DOI: 10.1210/jc.2010-2704. View

17.

Ferraris J, Pasqualini T, Alonso G, Legal S, Sorroche P, Galich A . Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients. Pediatr Nephrol. 2007; 22(5):734-41. DOI: 10.1007/s00467-006-0403-0. View

18.

Stasikelis P, Lee D, Sullivan C . Complications of osteotomies in severe cerebral palsy. J Pediatr Orthop. 1999; 19(2):207-10. DOI: 10.1097/00004694-199903000-00014. View

19.

Gniatkowska-Nowakowska A . Fractures in epilepsy children. Seizure. 2010; 19(6):324-5. DOI: 10.1016/j.seizure.2010.04.013. View

20.

Aydin K, Kartal A, Alp E . High rates of malnutrition and epilepsy: two common comorbidities in children with cerebral palsy. Turk J Med Sci. 2019; 49(1):33-37. PMC: 7350856. DOI: 10.3906/sag-1803-79. View